Advanced Materials 25 (2013) 4028-4034. Dielectrophoretically aligned carbon nanotubes to control electrical and mechanical properties of hydrogels for muscle tissue engineering. J. Ramón-Azcón, S. Ahadian, M. Estili, X. Liang, S. Ostrovidov, H. Kaji,H. Shiku, R. Murugan, K. Nakajima, Y. Sakka, A. Khademhosseini, T. Matsue.
Organogenesis 9 (2013) 87-91. Electrical simulation as a biomimicry tool for regulating muscle cell behavior. S. Ahadian, S. Ostrovidov, V. Hosseini, H. Kaji,R. Murugan, H. Bae and A. Khademhosseini.
J. Nanosci. Nanotech. 13 (2013) 4647-4655. Gradient nanofiber scaffolds for tissue engineering. Seidi, K. Sampathkumar, A. Srivastava, S. Ramakrishna and R. Murugan.
Asian Pacific J Cancer Prev. (2013) 14 (2), 631-637.Comparative Studies to Evaluate Relative in vitro Potency of Luteolin in Inducing Cell Cycle Arrest and Apoptosis in HaCaT and A375 Cells. George VC, Ragupathi D, Kumar N, Suresh PK, Kumar S, Ashok Kumar R.
Stem Cells Transl Med. 2013 Aug;2(8):607-13. Overcoming challenges to initiating cell therapy clinical trials in rapidly developing countries: India as a model. Viswanathan S, Rao M, Keating A, Srivastava A.
Rev Med Virol; 2013 Nov;23(6):399-413. Adeno-associated virus (AAV) vectors in gene therapy: Immune challenges and strategies to circumvent them. Sangeetha H, Balakrishnan B, Sen D, Kumar S, Srivastava A, Jayandharan GR.
Journal of the National Cancer Institute, 2013 Aug 21;105(16):1188-201. Effects of Vascular-Endothelial Protein Tyrosine Phosphatase Inhibition on Breast Cancer Vasculature and Metastatic Progression. Shom Goel, Nisha Gupta, Brian P. Walcott, Matija Snuderl, Cristina T. Kesler, Nathaniel D. Kirkpatrick, Takahiro Heishi, Yuhui Huang, John D. Martin, Eleanor Ager, Samuel R, Shuhan Wang, John Yazbek, Benjamin J. Vakoc, Randall T. Peterson, Timothy P. Padera, Dan G. Duda, Dai Fukumura and Rakesh K. Jain.
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12774-9. Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Samuel R, Laurence Daheron, Shan Liao, Trupti Vardam, Walid S. Kamoun, Ana Batista, Christa Buecker, Richard Schäfer, Xiaoxing Han, Patrick Au, David T. Scadden, Dan G. Duda, Dai Fukumura, and Rakesh K. Jain.
Nature. 2013;500:345-349. Featured in: Cell Stem Cell. 2013;13:137-138. Goodell MA. Parental Permissions: H19 and Keeping the Stem Cell Progeny under Control. Maternal imprinting at the H19–Igf2 locus maintains adult haematopoietic stem cell quiescence. Venkatraman A, Xi C. He, Joanne L. Thorvaldsen, Ryohichi Sugimura, John M. Perry, Fang Tao, Meng Zhao, Matthew K. Christenson, Rebeca Sanchez,, Jaclyn Y. Yu, Lai Peng, Jeffrey . Haug, Ariel Paulson, Hua Li, Xiao-bo Zhong, Thomas L. Clemens, Marisa S. Bartolomei & Linheng Li, .
Scientific Reports; 2013, 3: 1832. Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy. Sen D, Balakrishnan B, Gabriel N, Agrawal P, Roshini V, Samuel R, Srivastava A, Jayandharan GR.
Cytotherapy, Volume 15, Issue 8, August 2013, Pages 986–998. Optimizing the transduction efficiency of human hematopoietic stem cells using capsid-modified AAV6 vectors in vitro and in a xenograft mouse model in vivo. Song L, Kauss MA, Kopin E, Chandra M, Ul-Hasan T, Miller E, Jayandharan GR, Rivers AE, Aslanidi GV, Ling C, Li B, Ma W, Li X, Andino LA, Zhong L, Tarantal AF, Yoder MC, Wong KK, Jr, Tan M, Chatterjee S, Srivastava A.
Hum Gene Ther Methods. 2013 Apr;24(2):104-16.Targeted modifications in adeno-associated virus (AAV) serotype -8 capsid improves its hepatic gene transfer efficiency in vivo. Sen D, Gadkari RA, Sudha G, Gabriel N, Sathish Kumar Y, Selot R, Samuel R, Rajalingam S, Ramya V, Nair SC,Srinivasan N, Srivastava A, Jayandharan GR.
Hum Gene Ther Methods. 2013 Apr;24(2):80-93. Bio-Engineering of Adeno-Associated Virus Serotype (AAV)-2 Capsid at Serine/Threonine/Lysine Residues Improves Its Transduction Efficiency Both In Vitro and In Vivo.Gabriel N, Hareendran S, Sen D, Gadkari RA, Govindarajan S, Hussain M, Duraiswamy R, Samuel R, Srinivasan N, Srivastava A, Jayandharan GR.
PLoS One. 2013;8(3):e58757. High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.Song L, Li X, Jayandharan GR, Wang Y, Aslanidi GV, Ling C, Zhong L, Gao G, Yoder MC, Ling C, Tan M, Srivastava A.
J Thromb Haemost. 2013 Feb;11(2):293-306. Nuclear Factor (NF)-?B and its associated pathways are major regulators of blood induced joint damage in a murine model of hemophilia.Sen D, Chapla A, Walter N, Daniel V, Srivastava A, Jayandharan GR.
PLoS One 2013;8(1):e53845. Activation of the Cellular Unfolded Protein Response by Recombinant Adeno-Associated Virus Vectors. Balakrishnan B, Sen D, David S, Hareendran S, Srivastava A, Jayandharan GR.
R. Murugan, E. Jabbari, S. Ramakrishna and A. Khademhosseini.Micro and Nanotechnologies in Engineering Stem Cells and Tissues.IEEE Press, USA (2013) 328 pages.
R. Murugan, Xiumei Wang, Peter Yang, Guoping Chen and Fu-Zhai Cui. Biomimetics: Advancing Nanobiomaterials and Tissue Engineering. Wiley-Scrivener Publishing, USA (2013) 354 pages.
R. Murugan, P. Vallittu, U. Ripamonti and Wan-Ju Li. Tissue Engineering and Regenerative Medicine: A Nano Approach. CRC Press, USA (2013) 592 pages.
KaarunyaSampathkumar, AzadehSeidi, AlokSrivastava, T.S. Sampath Kumar, S. Ramakrishna and MuruganRamalingam. Biomimetic materials for engineering stem cells and tissues. In Biomimetics: Advancing Nanobiomaterials and Tissue Engineering, J R. Murugan, X. Wang, G. Chen, P. Ma and F-Z. Cui (Eds), Wiley-Scrivener Publication, USA (2013) 329-344.
S. Ahadian, R. Murugan and A. Khademhosseini. The emerging applications of graphene oxide and graphene in tissue engineering. In Biomimetics: Advancing Nanobiomaterials and Tissue Engineering, J R. Murugan, X. Wang, G. Chen, P. Ma and F-Z. Cui (Eds), Wiley-Scrivener Publication, USA (2013) 279-299.
S. Ostrovidov, A. Seidi, S. Ahadian, R. Murugan and A. Khademhosseini. Micro- and nanoengineering approaches for advancing gradient biomaterials suitable for interface tissue engineering. In Micro and Nanotechnologies in Engineering Stem cells and Tissues, R. Murugan, E. Jabbari, S. Ramakrishna and A. Khademhosseini (Eds), Wiley-IEEE Press, USA (2013) 52-80.
M. Shayanthi, J. Venugopal, R. Rajeswari, R. Murugan, M. Raghunath and S. Ramakrishna. Nanofiber technology for controlling stem cell functions and tissue engineering.In Micro and Nanotechnologies in Engineering Stem cells and Tissues, R. Murugan, J. E. Jabbari, S. Ramakrishna and A. Khademhosseini (Eds.) Wiley-IEEE Press, USA (2013) 27-52.
Peter Molnar, MuruganMurugan, and James J. Hickman. Surface chemical determination of placement, growth and differentiation of cells for drug screening, toxin detection and lab-on-a-chip applications. In Tissue Engineering and Regenerative Medicine: A Nano Approach, R. Murugan, P. Vallittu. U. Ripamonti and Wan-Ju Li (Eds.), CRC Press, USA (2013) 205-228.
Y.N. Cho,R. Murugan and Z.S. Haidar. Nanobiomaterial-based siRNA delivery systems.In Tissue Engineering and Regenerative Medicine: A Nano Approach, R. Murugan, P. Vallittu. U. Ripamonti and Wan-Ju Li (Eds.), CRC Press, USA (2013) 473-498.